Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (Sirolimus)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01675947
Recruitment Status : Terminated (On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur.)
First Posted : August 30, 2012
Last Update Posted : December 10, 2015
The EMMES Corporation
Santen Inc.
Information provided by (Responsible Party):
National Eye Institute (NEI)

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2015
  Estimated Study Completion Date : February 2016